P43235 (CATK_HUMAN) Homo sapiens (Human)
Cathepsin K UniProtKBInterProSTRINGInteractive Modelling
329 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
69 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Structure of Pycnonodysostosis disease related I249T mutant of human cathepsin K | homo-2-mer | 99.35 | 8×GOL; 16×EDO; 5×SO4; 7×PEG; 1×CL; 1×NA; 3×MPD; | |||
| CRYSTAL STRUCTURE OF WILD TYPE HUMAN PROCATHEPSIN K | homo-2-mer | 100 | ||||
| Structure of the activation intermediate of cathepsin K in complex with the 3-cyano-3-aza-beta-amin… | homo-2-mer | 100 | 1×A0U; 1×ACT; 1×MG; | |||
| Structure of the activation intermediate of cathepsin K in complex with the azadipeptide nitrile in… | homo-2-mer | 100 | 1×9ZG; 3×EDO; 1×CL; 1×MG; | |||
| The Alkyne Moiety as a Latent Electrophile in Irreversible Covalent Small Molecule Inhibitors of Ca… | homo-2-mer | 100 | 2×HVW; 1×CA; 2×CL; | |||
| Cathepsin K complexed with a ketoamide inhibitor | homo-2-mer | 100 | 3×SO4; 2×FSP; | |||
| Crystal structure of the cathepsin K : chondroitin sulfate complex. | homo-2-mer | 100 | 2×BDP; 2×CA; 2×E64; | |||
| THE CRYSTAL STRUCTURE OF HUMAN PROCATHEPSIN K | monomer | 100 | ||||
| Human cathepsin K mutant C25S in complex with the allosteric effector NSC13345 | monomer | 99.55 | 1×1XF; 1×SO4; | |||
| Human cathepsin K mutant C25S in complex with the allosteric effector NSC94914 | monomer | 99.55 | 1×6HM; 1×SO4; | |||
| Structure of cathepsin K in complex with the azadipeptide nitrile inhibitor Gu1303 | monomer | 100 | 1×9ZG; 1×CL; 1×ACT; | |||
| Cathepsin-K in complex with MIV-711 | monomer | 100 | 1×J5N; 6×NO3; | |||
| Cathepsin-K in complex with MIV-701 | monomer | 100 | 1×HFH; 1×GOL; 1×NA; | |||
| Structure of human cathepsin K in complex with the selective activity-based probe Gu3416 | monomer | 100 | 1×SO4; 1×UUW; | |||
| Structure of human cathepsin K in complex with the acrylamide inhibitor Gu3110 | monomer | 100 | 1×SO4; 1×UUK; | |||
| Cathepsin-K in complex with amino-oxaazabicyclo[3.3.0]octanyl containing inhibitor | monomer | 100 | 1×MHA; 1×J6B; | |||
| Crystal structure of a pyrrolopyrimidine inhibitor in complex with human Cathepsin K | monomer | 100 | 1×CKE; | |||
| Cathepsin-K in complex with MIV-710 | monomer | 100 | 1×J5T; 3×CL; 1×NA; | |||
| Crystal Structure of the Cysteine Protease Human Cathepsin K in Complex with the Covalent Inhibitor… | monomer | 100 | 1×IHJ; | |||
| Cathepsin-K in complex with fluoro-oxa-azabicyclo[3.3.0]octanyl containing inhibitor | monomer | 100 | 1×HKH; | |||
| Crystal Structure of the Cysteine Protease Human Cathepsin K in Complex with the Covalent Inhibitor… | monomer | 100 | 1×IHI; | |||
| Development of N-(Functionalized benzoyl)-homocycloleucyl-glycinonitriles as Potent Cathepsin K Inh… | monomer | 100 | 1×3XT; 1×I37; 6×SO4; | |||
| Crystal structure of Cathepsin K with a covalently-linked inhibitor at 1.4 Angstrom resolution. | monomer | 99.53 | 1×7AS; | |||
| Crystal structure of human Cathepsin K with a non-active site inhibitor at 1.42 Angstrom resolution | monomer | 99.53 | 3×1XF; | |||
| Cathepsin K in complex with a non-selective 2-cyano-pyrimidine inhibitor | monomer | 100 | 6×SO4; 1×KWZ; | |||
| Development of N-(Functionalized benzoyl)-homocycloleucyl-glycinonitriles as Potent Cathepsin K Inh… | monomer | 100 | 1×GOL; 1×CL; 1×K; 3×PGO; 1×3Y2; | |||
| Crystal structure of uninhibited human Cathepsin K at 1.62 Angstrom resolution | monomer | 100 | ||||
| Cathepsin K inhibitor | monomer | 100 | 1×0LC; 2×SO4; | |||
| Cathepsin K covalently bound to a 2-cyano pyrimidine inhibitor with a benzyl P3 group. | monomer | 100 | 2×SO4; 1×O75; | |||
| Cathepsin K inhibitor | monomer | 100 | 1×0LB; 1×GOL; | |||
| Cathepsin K covalently bound to a cyano-pyrimidine inhibitor with improved selectivity over hERG | monomer | 100 | 1×O47; | |||
| Crystal structure of Cathepsin K complexed with a potent vinyl sulfone inhibitor | monomer | 100 | 1×0D6; | |||
| X-ray structure of Cathepsin K covalently bound to a triazine ligand | monomer | 100 | 1×ORG; 1×TFA; | |||
| Structure of human Cathepsin K with an ectosteric inhibitor at 1.85 Angstrom resolution | monomer | 99.53 | 4×J0V; | |||
| Development of N-(Functionalized benzoyl)-homocycloleucyl-glycinonitriles as Potent Cathepsin K Inh… | monomer | 100 | 1×3Y1; 5×SO4; | |||
| Crystal structure of Human Cathepsin K in complex with myocrisin | monomer | 100 | 1×SO4; 1×MYQ; | |||
| Crystal structure of a potent small molecule inhibitor bound to cathepsin K | monomer | 93.02 | 1×NFT; | |||
| Cathepsin K complexed with a pyrrolidine ketoamide-based inhibitor | monomer | 100 | 1×4PR; | |||
| Sulfonated Calpeptin is a promising drug candidate against SARS-CoV-2 infections | monomer | 100 | 1×CA; | |||
| Structure of cathepsin K in complex with the 3-cyano-3-aza-beta-amino acid inhibitor Gu2602 | monomer | 100 | 1×A0U; | |||
| Structure of CatK covalently bound to a dioxo-triazine inhibitor | monomer | 100 | 1×ORH; | |||
| Cathepsin K complexed with t-butyl(1S)-1-cyclohexyl-2-oxoethylcarbamate | monomer | 100 | 1×SO4; 1×TCO; | |||
| CRYSTAL STRUCTURE OF CATHEPSIN K WITH N-DESMETHYL THALASSOSPIRAMIDE C | monomer | 100 | 1×G4B; | |||
| CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH THE COVALENT INHIBITOR… | monomer | 100 | 1×E64; | |||
| CRYSTAL STRUCTURE OF CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT SYMMETRIC BISCA… | monomer | 100 | 1×INA; | |||
| Crystal Structure of the Cysteine Protease Human Cathepsin K in Complex with the Covalent Inhibitor… | monomer | 100 | 1×IHE; | |||
| The crystal structure of the cathepsin K Variant M5 in complex with chondroitin-4-sulfate | monomer | 97.21 | 1×BDP; 1×CA; 1×E64; | |||
| CRYSTAL STRUCTURE OF CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT PEPTIDOMIMETIC … | monomer | 100 | 1×I10; | |||
| CRYSTAL STRUCTURE OF CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT THIAZOLHYDRAZID… | monomer | 100 | 1×IN6; | |||
| Cathepsin K complexed with a semicarbazone inhibitor | monomer | 100 | 3×SO4; 1×CT2; | |||
| CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT PYRROLIDINO… | monomer | 100 | 1×INP; | |||
| CRYSTAL STRUCTURE OF CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT BENZYLOXYBENZOY… | monomer | 100 | 1×IN3; | |||
| CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT AZEPANONE I… | monomer | 100 | 1×2CA; | |||
| Cathepsin K complexed with a cyanopyrrolidine inhibitor | monomer | 100 | 1×NBL; | |||
| CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT PYRROLIDINO… | monomer | 100 | 1×PCM; | |||
| CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT SYMMETRIC D… | monomer | 100 | 1×SDK; | |||
| CRYSTAL STRUCTURE OF THE CYSTEINE PROTEASE HUMAN CATHEPSIN K IN COMPLEX WITH A COVALENT PROPANONE I… | monomer | 100 | 1×POS; | |||
| Structure of Cathepsin K-dermatan sulfate complex | monomer | 100 | 1×ASG; | |||
| Crystal Structure Of The Cysteine Protease Human Cathepsin K In Complex With A Covalent Azepanone I… | monomer | 100 | 1×750; | |||
| Human cathepsin K mutant C25S | monomer | 99.53 | 2×SO4; 1×ACT; 1×CL; | |||
| Cathepsin K complexed with a constrained ketoamide inhibitor | monomer | 100 | 2×SO4; 1×3FC; | |||
| Cathepsin K complexed with carbamate derivatized norleucine aldehyde | monomer | 100 | 3×SO4; 1×MYE; | |||
| Cathepsin K in complex with a selective 2-cyano-pyrimidine inhibitor | monomer | 100 | 1×KX1; 2×SO4; | |||
| Cathepsin K co-crystallized with actinomycetes extract | monomer | 100 | 1×SO4; | |||
| Crystal structure of cathepsin K bound to the covalent inhibitor lichostatinal | monomer | 100 | 3×SO4; | |||
| cathepsin K - chondroitin sulfate complex | monomer | 100 | 1×BDP; | |||
| Cathepsin K complexed with a semicarbazone inhibitor | monomer | 100 | 1×CT1; | |||
| Cathepsin K complexed with a cyanamide-based inhibitor | monomer | 100 | 1×T2M; | |||
| Cathepsin K in complex with a covalent inhibitor with a ketoamide warhead | monomer | 100 | 1×O96; 2×SO4; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 5z5o.1.A | monomer | 0.89 | 99.36 | |||